| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | President and CEO | Common Stock | 826K | $4.03M | $4.88 | Mar 9, 2024 | Direct |
| Aquestive Therapeutics, Inc. | President and CEO | Non-Qualified Stock Option (right to buy) | 364K | Mar 7, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Mar 9, 2024 | 1 | -$277K | 4/A | Oct 2, 2024 | President and CEO |
| AQST | Aquestive Therapeutics, Inc. | Mar 7, 2024 | 2 | $0 | 4 | Mar 11, 2024 | President and CEO |
| AQST | Aquestive Therapeutics, Inc. | Aug 9, 2023 | 1 | $0 | 4 | Aug 9, 2023 | President and CEO |
| AQST | Aquestive Therapeutics, Inc. | May 5, 2023 | 1 | $0 | 4 | May 5, 2023 | President and CEO |
| AQST | Aquestive Therapeutics, Inc. | Mar 9, 2023 | 1 | $0 | 4 | Mar 9, 2023 | President and CEO |
| AQST | Aquestive Therapeutics, Inc. | Aug 5, 2022 | 1 | $0 | 4 | Aug 8, 2022 | President and CEO |
| AQST | Aquestive Therapeutics, Inc. | Jun 8, 2022 | 2 | $100K | 4 | Jun 10, 2022 | Chief Executive Officer |
| AQST | Aquestive Therapeutics, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 14, 2022 | SVP-Chief Operating Officer |